Posts

Pioneering Sylvester physician elected to Society of Neuro-Oncology board

Pioneering Sylvester physician elected to Society of Ne...

Nov 7, 2023

Macarena de la Fuente, MD, chief of neuro-oncology at Sylvester Comprehensive Ca...

Artificial intelligence enhances radiotherapy for Henry Ford Health patients with cancer

Artificial intelligence enhances radiotherapy for Henry...

Nov 7, 2023

Patients undergoing radiation therapy for certain types of cancer at Henry Ford ...

New, promising clinical trial for glioblastoma starting at UNC Health

New, promising clinical trial for glioblastoma starting...

Nov 7, 2023

UNC Health is now enrolling patients as part of a multicenter clinical trial for...

Deciphering reproductive aging in women using a NOD/SCID mouse model

Deciphering reproductive aging in women using a NOD/SCI...

Nov 7, 2023

“The proposed NOD/SCID model, with its accelerated ovarian aging, holds particul...

The annual economic burden of urinary incontinence could reach €87 billion in 2030 if no action is taken

The annual economic burden of urinary incontinence coul...

Nov 7, 2023

Brussels, 8 November 2023 – New international research on the economic burden of...

New compound shows early promise for treatment of Lou Gehrig’s disease in preclinical models

New compound shows early promise for treatment of Lou G...

Nov 7, 2023

In science, a simple but thorough observation can kick-start the most surprising...

Why a surprising discovery, warming seas and the demise of the ‘Meg’ may spell trouble for more and more sharks

Why a surprising discovery, warming seas and the demise...

Nov 7, 2023

Some unexpected shark strandings and subsequent surprises following autopsies ha...

Southern Alaska’s national forests key to meeting climate, conservation goals, OSU study shows

Southern Alaska’s national forests key to meeting clima...

Nov 7, 2023

CORVALLIS, Ore. – Analyses of U.S. national forests led by Oregon State Universi...

TLM-005 by Therillume for Glioblastoma Multiforme (GBM)...

Nov 6, 2023

TLM-005 is under clinical development by Therillume and currently in Phase I for...

TLM-004 by Therillume for Glioblastoma Multiforme (GBM)...

Nov 6, 2023

TLM-004 is under clinical development by Therillume and currently in Phase I for...

TLM-003 by Therillume for Glioblastoma Multiforme (GBM)...

Nov 6, 2023

TLM-003 is under clinical development by Therillume and currently in Phase I for...

StromaForte by Swedish StromaBio for Cardiovascular Dis...

Nov 6, 2023

StromaForte is under clinical development by Swedish StromaBio and currently in ...

Fulvestrant by Kashiv BioSciences for Metastatic Breast...

Nov 6, 2023

Fulvestrant is under clinical development by Kashiv BioSciences and currently in...

TLM-101 by Therillume for Neurofibromatoses Type I (Von...

Nov 6, 2023

TLM-101 is under clinical development by Therillume and currently in Phase I for...

TLM-006 by Therillume for Glioblastoma Multiforme (GBM)...

Nov 6, 2023

TLM-006 is under clinical development by Therillume and currently in Phase I for...

AWT-020 by Anwita Biosciences for Lymphoma: Likelihood ...

Nov 6, 2023

AWT-020 is under clinical development by Anwita Biosciences and currently in Pha...